{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:08:58Z","timestamp":1780355338357,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s13346-018-0562-0","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T11:12:54Z","timestamp":1531825974000},"page":"1365-1379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity"],"prefix":"10.1007","volume":"8","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuifang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2013.10.007","volume":"71","author":"LH Reddy","year":"2014","unstructured":"Reddy LH, Bazile D. Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics. Adv Drug Deliv Rev. 2014;71:34\u201357.","journal-title":"Adv Drug Deliv Rev"},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2017.09.029","volume":"410","author":"B Hoang","year":"2017","unstructured":"Hoang B, Ernsting MJ, Tang WHS, Bteich J, Undzys E, Kiyota T, et al. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer. Cancer Lett. 2017;410:169\u201379.","journal-title":"Cancer Lett"},{"issue":"9760","key":"562_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0140-6736(11)60013-5","volume":"377","author":"M Froehner","year":"2011","unstructured":"Froehner M, Wirth MP. Cabazitaxel for castration-resistant prostate cancer. Lancet. 2011;377(9760):122\u20133.","journal-title":"Lancet"},{"issue":"1","key":"562_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2013.09.024","volume":"52","author":"Y Shao","year":"2014","unstructured":"Shao Y, Zhang C, Yao Q, Wang Y, Tian B, Tang X, et al. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences. 2014;52(1):1\u201311.","journal-title":"European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences"},{"issue":"4","key":"562_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/fon.11.23","volume":"7","author":"S Oudard","year":"2011","unstructured":"Oudard S. TROPIC: phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer. Future Oncol. 2011;7(4):497\u2013506.","journal-title":"Future Oncol"},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.fbp.2016.01.014","volume":"98","author":"YN Shariffa","year":"2016","unstructured":"Shariffa YN, Tan TB, Abas F, Mirhosseini H, Nehdi IA, Tan CP. Producing a lycopene nanodispersion: the effects of emulsifiers. Food & Bioproducts Processing. 2016;98:210\u20136.","journal-title":"Food & Bioproducts Processing"},{"issue":"1","key":"562_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF01964882","volume":"7","author":"W Lorenz","year":"1977","unstructured":"Lorenz W, Reimann HJ, Schmal A, Dormann P, Schwarz B, Neugebauer E, et al. Histamine release in dogs by Cremophor El \u00ae and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions. 1977;7(1):63\u20137.","journal-title":"Agents Actions"},{"issue":"1","key":"562_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF01054722","volume":"25","author":"HH Boer","year":"1995","unstructured":"Boer HH, Moorer-van Delft CM, M\u00fcller LJ, Kiburg B, Vermorken JB, Heimans JJ. Ultrastructural neuropathologic effects of Taxol on neurons of the freshwater snail Lymnaea stagnalis. J Neuro-Oncol. 1995;25(1):49\u201357.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"562_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1212\/WNL.46.1.104","volume":"46","author":"PHE Hilkens","year":"1996","unstructured":"Hilkens PHE, Verweij J, Stoter G, Vecht CJ, Putten WLJV, Bent MJVD. Peripheral neurotoxicity induced by docetaxel. Neurology. 1996;46(1):104\u20138.","journal-title":"Neurology"},{"issue":"11","key":"562_CR10","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2007.15.8485","volume":"27","author":"S Chan","year":"2009","unstructured":"Chan S, Romieu G, Huober J, Delozier T, Tubiana-Hulin M, Schneeweiss A, et al. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology. 2009;27(11):1753\u201360.","journal-title":"Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology"},{"issue":"7","key":"562_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/09205063.2016.1146980","volume":"27","author":"X Han","year":"2016","unstructured":"Han X, Chen D, Sun J, Zhou J, Li D, Gong F, et al. A novel cabazitaxel-loaded polymeric micelle system with superior in vitro stability and long blood circulation time. Journal of Biomaterials Science Polymer Edition. 2016;27(7):626\u201342.","journal-title":"Journal of Biomaterials Science Polymer Edition"},{"key":"562_CR12","unstructured":"Satyavathi K, Bhojaraju P, Srikanthi M, Sudhakar P. Formulation and in-vitro evaluation of liposomal drug delivery system of cabazitaxel. Journal of Pharmaceutics & Drug Delivery Research 2016."},{"key":"562_CR13","doi-asserted-by":"crossref","unstructured":"Qu N, Sun Y, Xie J, Teng L. Preparation and evaluation of in vitro self-assembling HSA nanoparticles for cabazitaxel. Anti Cancer Agents Med Chem (Formerly Current Medicinal Chemistry - Anti-Cancer Agents). 2016;17(2):-.","DOI":"10.2174\/1871520616666160526103102"},{"issue":"6","key":"562_CR14","first-page":"450","volume":"63","author":"V Venkateswarlu","year":"2001","unstructured":"Venkateswarlu V. Lipid microspheres as drug delivery systems. Indian J Pharm Sci. 2001;63(6):450\u20138.","journal-title":"Indian J Pharm Sci"},{"issue":"11","key":"562_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/03639040802005057","volume":"34","author":"K Liu","year":"2008","unstructured":"Liu K. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Development & Industrial Pharmacy. 2008;34(11):1227.","journal-title":"Drug Development & Industrial Pharmacy"},{"issue":"2","key":"562_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145\u201360.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"562_CR17","first-page":"532","volume":"81","author":"N\u00d8 Knudsen","year":"2012","unstructured":"Knudsen N\u00d8, R\u00f8nholt S, Salte RD, Jorgensen L, Thormann T, Basse LH, et al. Calcipotriol delivery into the skin with PEGylated liposomes. European Journal of Pharmaceutics & Biopharmaceutics Official Journal of Arbeitsgemeinschaft F\u00fcr Pharmazeutische Verfahrenstechnik E V. 2012;81(3):532\u20139.","journal-title":"European Journal of Pharmaceutics & Biopharmaceutics Official Journal of Arbeitsgemeinschaft F\u00fcr Pharmazeutische Verfahrenstechnik E V"},{"issue":"12","key":"562_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2174\/1381612821666150115144003","volume":"21","author":"J Che","year":"2015","unstructured":"Che J, Okeke CI, Hu ZB, Xu J. DSPE-PEG: a distinctive component in drug delivery system. Curr Pharm Des. 2015;21(12):1598\u2013605.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"562_CR19","first-page":"255","volume":"47","author":"K Zurowskapryczkowska","year":"1999","unstructured":"Zurowskapryczkowska K, Sznitowska M, Janicki S. Studies on the effect of pilocarpine incorporation into a submicron emulsion on the stability of the drug and the vehicle. European Journal of Pharmaceutics & Biopharmaceutics Official Journal of Arbeitsgemeinschaft F\u00fcr Pharmazeutische Verfahrenstechnik E V. 1999;47(3):255.","journal-title":"European Journal of Pharmaceutics & Biopharmaceutics Official Journal of Arbeitsgemeinschaft F\u00fcr Pharmazeutische Verfahrenstechnik E V."},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.foodchem.2016.02.155","volume":"205","author":"F Liu","year":"2016","unstructured":"Liu F, Wang D, Sun C, Mcclements DJ, Gao Y. Utilization of interfacial engineering to improve physicochemical stability of \u03b2-carotene emulsions: multilayer coatings formed using protein and protein-polyphenol conjugates. Food Chem. 2016;205:129\u201339.","journal-title":"Food Chem"},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ejps.2017.09.022","volume":"109","author":"L Luo","year":"2017","unstructured":"Luo L, Wang X, Chen Q, Miao L, Zhuo X, Liu L, et al. A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo. Eur J Pharm Sci. 2017;109:638\u201349.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"562_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ajps.2016.04.002","volume":"11","author":"H Gong","year":"2016","unstructured":"Gong H, Geng S, Zheng Q, Wang P, Luo L, Wang X, et al. An intravenous clarithromycin lipid emulsion with a high drug loading, H-bonding and a hydrogen-bonded ion pair complex exhibiting excellent antibacterial activity. Asian Journal of Pharmaceutical Sciences. 2016;11(5):618\u201330.","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"2","key":"562_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jconrel.2006.02.012","volume":"112","author":"J Heyes","year":"2006","unstructured":"Heyes J, Hall K, Tailor V, Lenz R, Maclachlan I. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. J Control Release. 2006;112(2):280\u201390.","journal-title":"J Control Release"},{"issue":"1","key":"562_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijpharm.2016.06.046","volume":"510","author":"HA Rydberg","year":"2016","unstructured":"Rydberg HA, Arteta MY, Berg S, Lindfors L, Sigfridsson K. Probing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystals. Int J Pharm. 2016;510(1):232\u20139.","journal-title":"Int J Pharm"},{"issue":"1","key":"562_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF01964882","volume":"7","author":"W Lorenz","year":"1977","unstructured":"Lorenz W, Reimann HJ, Schmal A, Dormann P, Schwarz B, Neugebauer E, et al. Histamine release in dogs by Cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions. 1977;7(1):63\u20137.","journal-title":"Agents Actions"},{"issue":"4","key":"562_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ejlt.201400160","volume":"117","author":"Y Shao","year":"2015","unstructured":"Shao Y, Li S, Tian B, Su L, Zhang C, Wang Y, et al. Evaluation of the stability and pharmacokinetics of cabazitaxel-loaded intravenous lipid microspheres: beneficial effect of cholesterol. European Journal of Lipid Science & Technology. 2015;117(4):460\u201370.","journal-title":"European Journal of Lipid Science & Technology"},{"issue":"9","key":"562_CR27","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1021\/acs.biomac.5b00826","volume":"16","author":"J Gou","year":"2015","unstructured":"Gou J, Feng S, Xu H, Fang G, Chao Y, Zhang Y, et al. Decreased core crystallinity facilitated drug loading in polymeric micelles without affecting their biological performances. Biomacromolecules. 2015;16(9):2920\u20139.","journal-title":"Biomacromolecules"},{"issue":"5","key":"562_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/17425247.2013.769954","volume":"10","author":"W Dong","year":"2013","unstructured":"Dong W, Zhang L, Niu Y, Fan D, Wu X, Tang X, et al. A stable and practical etoposide-containing intravenous long\u2212\/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy. Expert Opinion on Drug Delivery. 2013;10(5):559\u201371.","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"5","key":"562_CR29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/10717544.2014.885998","volume":"22","author":"H Xu","year":"2015","unstructured":"Xu H, Ye F, Hu M, Yin P, Zhang W, Li Y, et al. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection. Drug Delivery. 2015;22(5):598\u2013607.","journal-title":"Drug Delivery"},{"issue":"27","key":"562_CR30","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/25\/27\/275103","volume":"25","author":"S Geng","year":"2014","unstructured":"Geng S, Yang B, Wang G, Qin G, Wada S, Wang JY. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina. Nanotechnology. 2014;25(27):275103.","journal-title":"Nanotechnology"},{"issue":"8","key":"562_CR31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11095-010-0180-0","volume":"27","author":"M Zhao","year":"2010","unstructured":"Zhao M, Su MX, Luo Y, He H, Cai C, Tang X. Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity. Pharm Res. 2010;27(8):1687\u2013702.","journal-title":"Pharm Res"},{"issue":"1","key":"562_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijpharm.2017.07.011","volume":"529","author":"X Zhu","year":"2017","unstructured":"Zhu X, Tsendayush A, Yuan Z, Wen J, Cai J, Luo S, et al. Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy. Int J Pharm. 2017;529(1):451\u201364.","journal-title":"Int J Pharm"},{"issue":"1","key":"562_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1158\/1535-7163.MCT-14-0155","volume":"14","author":"GE Duran","year":"2015","unstructured":"Duran GE, Wang YC, Francisco EB, Rose JC, Martinez FJ, Coller J, et al. Mechanisms of resistance to cabazitaxel. Mol Cancer Ther. 2015;14(1):193\u2013201.","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"562_CR34","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1517\/17425247.2012.724675","volume":"9","author":"X Lin","year":"2012","unstructured":"Lin X, Zhang B, Zhang K, Zhang Y, Wang J, Qi N, et al. Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity. Expert Opinion on Drug Delivery. 2012;9(12):1449\u201362.","journal-title":"Expert Opinion on Drug Delivery."},{"issue":"1","key":"562_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007691-198810010-00001","volume":"10","author":"DE Drayer","year":"1988","unstructured":"Drayer DE. Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man. Ther Drug Monit. 1988;10(1):1\u20137.","journal-title":"Ther Drug Monit"},{"issue":"6","key":"562_CR36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.plipres.2004.09.001","volume":"43","author":"S Tamilvanan","year":"2004","unstructured":"Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Prog Lipid Res. 2004;43(6):489\u2013533.","journal-title":"Prog Lipid Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-018-0562-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-018-0562-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T19:16:44Z","timestamp":1563304604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-018-0562-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s13346-018-0562-0","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]},"assertion":[{"value":"17 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}